Ceva Animal Health Inc — licence 102054, currently licensed, last inspection rating C (2024-07-31).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02525704 | CREDELIO PLUS | ELANCO CANADA LIMITED | Tablet (Chewable) | MILBEMYCIN OXIME 16.88 MG; LOTILANER 450 MG | Marketed |
| 02525690 | CREDELIO PLUS | ELANCO CANADA LIMITED | Tablet (Chewable) | MILBEMYCIN OXIME 8.44 MG; LOTILANER 225 MG | Marketed |
| 02525682 | CREDELIO PLUS | ELANCO CANADA LIMITED | Tablet (Chewable) | MILBEMYCIN OXIME 4.22 MG; LOTILANER 112.5 MG | Marketed |
| 02525712 | CREDELIO PLUS | ELANCO CANADA LIMITED | Tablet (Chewable) | MILBEMYCIN OXIME 33.75 MG; LOTILANER 900 MG | Marketed |
| 02525674 | CREDELIO PLUS | ELANCO CANADA LIMITED | Tablet (Chewable) | MILBEMYCIN OXIME 2.11 MG; LOTILANER 56.25 MG | Marketed |
| 02141396 | INTERCEPTOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 23 MG | Marketed |
| 02141418 | INTERCEPTOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 11.5 MG | Marketed |
| 02141426 | INTERCEPTOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 5.75 MG | Marketed |
| 02141434 | INTERCEPTOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 2.3 MG | Marketed |
| 02468379 | INTERCEPTOR PLUS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 23 MG; PRAZIQUANTEL 228 MG | Marketed |
| 02468344 | INTERCEPTOR PLUS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 2.3 MG; PRAZIQUANTEL 22.8 MG | Marketed |
| 02468352 | INTERCEPTOR PLUS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 5.75 MG; PRAZIQUANTEL 57 MG | Marketed |
| 02468360 | INTERCEPTOR PLUS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 11.5 MG; PRAZIQUANTEL 114 MG | Marketed |
| 02556154 | MILBEGUARD DUO | CEVA ANIMAL HEALTH INC | Tablet | MILBEMYCIN OXIME 4 MG; PRAZIQUANTEL 10 MG | Approved |
| 02291959 | MILBEMAX | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 16 MG; PRAZIQUANTEL 40 MG | Marketed |
| 02291940 | MILBEMAX | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 4 MG; PRAZIQUANTEL 10 MG | Marketed |
| 02016729 | INTERCEPTOR CHEWABLE TAB 23MG | CIBA-GEIGY CANADA LTD, ANIMAL HEALTH DIVISION | Tablet | MILBEMYCIN OXIME 23 MG | Cancelled Post Market |
| 00846449 | INTERCEPTOR TAB 11.5MG | CIBA-GEIGY CANADA LTD, ANIMAL HEALTH DIVISION | Tablet | MILBEMYCIN OXIME 11.5 MG | Cancelled Post Market |
| 00846422 | INTERCEPTOR TAB 2.3MG | CIBA-GEIGY CANADA LTD, ANIMAL HEALTH DIVISION | Tablet | MILBEMYCIN OXIME 2.3 MG | Cancelled Post Market |
| 00846457 | INTERCEPTOR TAB 23MG | CIBA-GEIGY CANADA LTD, ANIMAL HEALTH DIVISION | Tablet | MILBEMYCIN OXIME 23 MG | Cancelled Post Market |
| 00846430 | INTERCEPTOR TAB 5.75MG | CIBA-GEIGY CANADA LTD, ANIMAL HEALTH DIVISION | Tablet | MILBEMYCIN OXIME 5.75 MG | Cancelled Post Market |
| 02246889 | MILBEMITE | ELANCO CANADA LIMITED | Solution | MILBEMYCIN OXIME 0.1 % | Cancelled Post Market |
| 02238148 | SENTINEL FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 11.5 MG; LUFENURON 230 MG | Cancelled Post Market |
| 02238147 | SENTINEL FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 23 MG; LUFENURON 460 MG | Cancelled Post Market |
| 02238149 | SENTINEL FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 5.75 MG; LUFENURON 115 MG | Cancelled Post Market |
| 02238150 | SENTINEL FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | MILBEMYCIN OXIME 2.3 MG; LUFENURON 46 MG | Cancelled Post Market |
| 02229547 | SENTINEL TABLETS 115/5.75 | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | MILBEMYCIN OXIME 5.75 MG; LUFENURON 115 MG | Cancelled Post Market |
| 02229548 | SENTINEL TABLETS 230/11.5 | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | MILBEMYCIN OXIME 11.5 MG; LUFENURON 230 MG | Cancelled Post Market |
| 02229551 | SENTINEL TABLETS 46/2.3 | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | MILBEMYCIN OXIME 2.3 MG; LUFENURON 46 MG | Cancelled Post Market |
| 02229549 | SENTINEL TABLETS 460/23 | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | MILBEMYCIN OXIME 23 MG; LUFENURON 460 MG | Cancelled Post Market |